Inventor
LANGHAM BARRY JOHN
GB24 patents
⚠️ This page may combine multiple inventors who share the name “LANGHAM BARRY JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CELLTECH R&D LTD
10 patentsUS6518283B1Feb 11, 2003
Squaric acid derivatives
CELLTECH R&D LTD64 citations96
US6610700B2Aug 26, 2003
Enamine derivatives
CELLTECH R&D LTD13 citations83
US7423047B2Sep 9, 2008
Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitors
CELLTECH R&D LTD8 citations73
US6780874B2Aug 24, 2004
Enamine derivatives
CELLTECH R&D LTD8 citations73
US7176215B2Feb 13, 2007
Bicyclic oxopyridine and oxopyrimidine derivatives
CELLTECH R&D LTD3 citations62
US6455539B2Sep 24, 2002
Squaric acid derivates
CELLTECH R&D LTD4 citations62
US6403608B1Jun 11, 2002
3-Substituted isoquinolin-1-yl derivatives
CELLTECH R&D LTD3 citations62
US7323464B2Jan 29, 2008
Pyridine and pyrimidine derivatives
CELLTECH R&D LTD3 citations58
US6740654B2May 25, 2004
Squaric acid derivatives
CELLTECH R&D LTD0 citations41
US6545013B2Apr 8, 2003
2,7-naphthyridine derivatives
CELLTECH R&D LTD0 citations41
UCB PHARMA SA
6 patentsUS7592455B2Sep 22, 2009
Bicyclic heteroaromatic compounds as kinase inhibitors
UCB PHARMA SA16 citations84
US7521460B2Apr 21, 2009
Thienopyridone derivatives as kinase inhibitors
UCB PHARMA SA17 citations84
US7763729B2Jul 27, 2010
Bicyclic heteroaromatic derivatives
UCB PHARMA SA2 citations62
US8604051B2Dec 10, 2013
Thieno-pyridine derivatives as MEK inhibitors
UCB PHARMA SA1 citations51
US8350037B2Jan 8, 2013
Thieno-pyridine derivatives as MEK inhibitors
UCB PHARMA SA1 citations51
US7456286B2Nov 25, 2008
Bicyclic heteroaromatic compounds as kinase inhibitors
UCB PHARMA SA1 citations49